<DOC>
	<DOCNO>NCT00143728</DOCNO>
	<brief_summary>The purpose study compare effect continue discontinue 3TC treatment presence HIV virus 3TC resistance person regimen include least three anti-HIV drug . The overall aim determine whether continue 3TC benefit HIV-positive person already show resistance drug .</brief_summary>
	<brief_title>3TC No 3TC HIV With 3TC Resistance</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Be HIV positive Be least 18 year old . Currently receive 3TC HIV infection conjunction least three antiretroviral drug . Must start regimen least three month prior start study . A plasma viral load le 50 copies/mL least two occasion ( measure least 28 day apart immediately prior screening ) . Evidence resistance 3TC Pregnancy breastfeeding . Hepatitis B surface antigen ( HbsAg ) positive time screen previous year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>HIV</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>